GKOS.NYSEGlaukos CORP

Form 4: Glaukos Officer Trades Shares

Sentiment:

Statement of Changes in Beneficial Ownership


Glaukos Corp. reports a transaction involving shares held by Chief Development Officer Tomas Navratil.

Summary

  • Tomas Navratil, Chief Development Officer at Glaukos Corp., engaged in a transaction involving common stock.
  • The transaction occurred on June 25, 2026.
  • 483 shares were disposed of, with a transaction price of $142.57 per share.
  • Following this transaction, Navratil beneficially owns 88,350 shares.
  • This ownership includes 38,817 restricted stock units that are yet to vest.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine disclosure of an insider transaction with a relatively small number of shares disposed of, while a significant number of shares and RSUs remain held by the executive.

Positives

  • The reporting person, Tomas Navratil, continues to hold a significant number of shares (88,350) after the transaction.
  • A substantial portion of the reported shares (38,817) are restricted stock units, indicating ongoing incentive alignment with the company's performance.

Negatives

  • 483 shares were disposed of by a key executive, which could be interpreted negatively by the market, although the amount is small relative to total holdings.

Risks

  • The filing does not explicitly mention any risks associated with this transaction.

Future Outlook

The filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions and provide transparency into executive stock dealings. The specific details of this transaction, including the number of shares and the nature of remaining holdings (RSUs), are important for investors to monitor executive confidence and compensation structures within the medical technology sector.

Stakeholder Impact

  • Shareholders: The disposal of shares by an executive may be observed, but the overall impact is likely minimal given the executive's continued substantial holdings and unvested RSUs.

Next Steps

  • Continued monitoring of insider transactions for Glaukos Corp.

Key Dates

DateDescription
03/18/2021Date of grant for previously issued restricted stock units.
06/25/2026Transaction date for the disposal of common stock.
06/29/2026Date of signature for the filing.

Keywords

Glaukos Corp, GKOS, Form 4, Insider Trading, Stock Transaction, Beneficial Ownership, Restricted Stock Units, Tomas Navratil

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.